![](https://privsource-prod.s3.amazonaws.com/tz3wmxxtcc9t5smvbm7ki3vad75j?response-content-disposition=inline%3B%20filename%3D%22Pharos.jpeg%22%3B%20filename%2A%3DUTF-8%27%27Pharos.jpeg&response-content-type=image%2Fjpeg&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6NYHEBQEVFIPN3SJ%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T093738Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=51a3ea14f7a071554d9d4743cca559e93005779b46650fd6a62c257d6da30f68)
Pharos Capital Group Invests in Sanderling Renal Services
05.16.2022
Sanderling is a full-service provider of dialysis and renal telemedicine services focusing on patients in underserved communities across the U.S. The company currently provides in-center and home-based dialysis out of 14 clinics in six states with a focus on communities with limited access to healthcare resources. Sanderling also leverages its network to provide tele-nephrology and acute eDialysis services to 30+ partner hospitals, more than two-thirds of which are located in USDA-defined rural areas across 16 states.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →